Status:
COMPLETED
Evaluation of the Artificial Intelligence-based Prescription Support Software iAST® for the Choice of Empirical and Semi-targeted Antibiotic Treatment
Lead Sponsor:
Pragmatech AI Solutions
Collaborating Sponsors:
NAMSA
Grupo Hospital de Madrid
Conditions:
Bacterial Infections
Eligibility:
All Genders
18+ years
Brief Summary
Inadequate treatment of infections frequently leads to complications that cause new visits to the doctor, lengthen hospital stays and can lead to sepsis, even causing the death of affected patients. S...
Detailed Description
Background: Infections are one of the main causes of consultation in primary care and emergency services. In addition, a high percentage of the patients admitted to hospitals suffer from an infection...
Eligibility Criteria
Inclusion
- Data for analysis should proceed from subjects over 18 years old that were admitted into HM Hospitals from 01Feb2023.
- Subjects who:
- have attended the Emergency Department of the hospital with suspected urinary tract infection (UTI) or;
- have presented an episode of bacteremia/sepsis at/during hospital admission or;
- have been admitted to the hospital ICU and presented a tracheobronchitis or pneumonia associated with mechanical ventilation or;
- have presented another type of infection, were treated and which have a bacterium identified with an antibiogram result.
Exclusion
- Patients with concomitant infections.
- Data from subjects suffered from infections with no bacterial etiology: fungal or viral infections.
- Data from subjects with infections without microbiological documentation (including antibiogram results).
- Data from subjects prescribed with more than one antibiotic.
Key Trial Info
Start Date :
August 1 2023
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
December 1 2023
Estimated Enrollment :
325 Patients enrolled
Trial Details
Trial ID
NCT06174519
Start Date
August 1 2023
End Date
December 1 2023
Last Update
December 22 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Grupo HM Hospitales
Madrid, Spain, 28015